Next 10 |
home / stock / adk:cc / adk:cc news
BROSSARD, Quebec, May 06, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or “the Company”) (TSX Venture: ADK) (OTCQB: DGNOF), a provider of healthcare services in early detection of certain critical health issues, in collaboration with ETS, École de Technologie ...
BROSSARD, Quebec, April 16, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or “the Company”) (TSX Venture: ADK) (OTCQB: DGNOF), a provider of healthcare services in early detection of certain critical health issues, announces today that it is working on getting new H...
NEW YORK, April 12, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the AI & Technology Hybrid Virtual Investor Conference presented by Water Tower Research held April 10 th and April 11 th...
NEW YORK, April 09, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the AI & Technology Hybrid Investor Conference presented by Water Tower Research to be held April 10 and 11. The two-day conference wil...
MONTREAL, April 09, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (ADK TSX: OTCQB: DGNOF), based in Montreal, Canada, focused on Artificial Intelligence for the medical market, today announced that André Larente, CEO, will present live at the AI & Technology Hybrid Virtual Investor Conferenc...
MONTREAL, April 09, 2024 (GLOBE NEWSWIRE) -- DIAGNOS inc. (ADK TSX: OTCQB: DGNOF), based in Montreal, Canada, focused on Artificial Intelligence for the medical market, today announced that Andre Larente, CEO, will present live at the AI & Technology Hybrid Virtual Investor Conferenc...
BROSSARD, Quebec, April 02, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. ("DIAGNOS" or the "Corporation") (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through the use of Artificial Intelligence ( AI ) technologies, is pleased to announce the appointment o...
2024-03-27 17:08:02 ET Starting clinical trials with the second largest hospital group in the U.S. Diagnos is an AI company. They have been a leader in artificial intelligence and healthcare technical services since 2001. Their company mission is to develop AI tools to assist ...
2024-03-27 17:08:02 ET An AI company Diagnos is a publicly-traded Canadian corporation dedicated to early detection of critical health problems based on its FLAIRE Artificial Intelligence (AI) platform. FLAIRE allows for quick modifying and development of applications such as CARA...
BROSSARD, Quebec, March 22, 2024 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through the use of Artificial Intelligence ( AI ) technologies, announces th...
News, Short Squeeze, Breakout and More Instantly...
Diagnos Inc. Company Name:
ADK:CC Stock Symbol:
TSXVC Market:
BROSSARD, Quebec, May 06, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or “the Company”) (TSX Venture: ADK) (OTCQB: DGNOF), a provider of healthcare services in early detection of certain critical health issues, in collaboration with ETS, École de Technologie ...
BROSSARD, Quebec, April 16, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or “the Company”) (TSX Venture: ADK) (OTCQB: DGNOF), a provider of healthcare services in early detection of certain critical health issues, announces today that it is working on getting new H...
NEW YORK, April 12, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the AI & Technology Hybrid Virtual Investor Conference presented by Water Tower Research held April 10 th and April 11 th...